Dr Farah Houdroge
Research Officer
Working groups
Background
Dr Farah Houdroge is a mathematical modeller at the Burnet Institute working across a variety of projects related infectious disease modelling and public health including BBV and STI elimination, resource optimisation analyses and statistical analyses, with a vested interest in climate change and health. Farah has a background in Applied Mathematics and Physics.
In 2017, she completed her PhD in Computational Fluid Dynamics at Monash University where, prior to joining the Burnet Institute, she worked as a Research Assistant and Teaching Associate in the Department of Mechanical and Aerospace Engineering.
Qualifications
- 2017: PhD in Computational Fluid Dynamics, Monash University, Melbourne, Australia
- 2013: MSc in Fluid Dynamics Research, Paul Sabatier University, Toulouse, France
- 2011: BSc in Mathematics and Applications, Paul Sabatier University, Toulouse, France
Awards
- 2014-2017: Faculty of Engineering International Postgraduate Research Scholarship (FEIPRS)
- 2014-2017: Monash Departmental Stipend Scholarship (MDS)
Positions
- 2020-ongoing: Mathematical Modeller, Burnet Institute, Melbourne, Australia
- 2020: Co-lecturer, Monash University, Melbourne, Australia
- 2014-2020: Head Teaching Associate, Monash University, Melbourne, Australia
- 2017-2019: Research Assistant, Monash University, Melbourne, Australia
Burnet publications
View 6 morePrison needle programs could save double what they cost – our new modelling shows how
Farah Houdroge, Mark Stoové, Nick Scott
The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study
The Medical Journal of Australia
Farah Houdroge et al
Cost–benefit analysis of Canada’s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections
Canadian Medical Association Journal
Farah Houdroge et al
News and features
Prison needle programs could save millions
Burnet research shows how prison needle and syringe programs could save treatment costs for hepatitis C and injection-related infections.
Prison needle programs could save double what they cost – our new modelling shows how
Australia leads the world in community-based needle and syringe programs. But they are not used in Australian prisons – which are hotspots for injection-related infections.